Alternative synthesis of the chiral atypical β-adrenergic phenylethanolaminotetraline agonist SR58611A using enantioselective hydrogenation

Tetrahedron Letters

Volumn 40, Issue 24, 1999, Pages 4551-4554

  Devocelle, Marc ^a   Mortreux, André ^a   Agbossou, Francine ^a   Dormoy, Jean Robert ^b  

^a Ecole Nationale Superieure de Chimie de Lille   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

[[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER; AMIDE; AMINOALCOHOL; AMINOKETONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; CHEMICAL STRUCTURE; CHIRALITY; CRYSTALLIZATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER;

EID: 0033546106     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)00807-2     Document Type: Article

References (21)

1. 1. (a) Lands, A. M.; Arnold, A.; McAuliff, J. P.; Luduena, F. P.; Brown, T. G. Jr. Nature 1967, 214, 597-698.
2. (b) Kirkiacharian, S. "Guide de Chimie Thérapeutique" Ellipses édition marketing . A., 1996, Chap. 8, pp 149-166.
3. 2. Arch, J. R. S.; Ainsworth, A. T.; Cawthorne, M. A.; Piercy, V.; Sennitt, M. V.; Thody, V. E.; Wilson, C.; Wilson, S. Nature 1984, 309, 163-165.
4. 3. Ainsworth, A. T.; Cawthorne, M. A. Eur. Pat. Appl. EP 170,121. Chem. Abstr. 1986, 104, 24720.
5. 4. Bloom, J. D.; Dutia, M. D.; Johnson, B. D.; Wissner, A.; Burns, M. G.; Largis, E. E.; Dolan, J. A.; Claus, T. H. J. Med. Chem. 1992, 35, 3081-3084.
6. 5. Alig, L.; Mueller, M. Eur. Pat. Appl. EP 386, 603. Chem. Abstr. 1991, 114, 163719.
7. 6. Shiro, K. Hiroshi, H.; Yoshimi, H.; Naoyuki, Y.; Hitoshi, K. PCT Int. Appl. WO 96 16,938. Chem. Abstr. 1996, 725, 142550.
8. 7. (a) Cecchi, R.; Croci, T.; Boijegrain, R.; Boveri, S.; Baroni, M.; Boccardi, G.; Guimbard, J. P.; Guzzi, U. Eur. J. Med. Chem. 1994, 29, 259-267.
9. (b) Badone, D.; Guzzi, U. Bioorg. Med. Chem. Lett. 1994, 4, 1921-1924.
10. 8. For the prior to ring closure stoichiometric reductions of functionalized ketones involving chiral oxazaborolidine derivatives see: (a) Corey, E. J.; Bakshi, R. K.; Shibata, S. J. Am. Chem. Soc. 1987, 109, 5551-5553.
11. (b) Corey, E. J.; Bakshi, R. K.; Shibata, S.; Chen, C.; Singh, V. K. J. Am. Chem. Soc. 1987, 109, 7925-7926.
12. 9. For enantioselective hydrogenation of functionalized ketones see: (a) Sayo, N.; Kumobayashi, H.; Akutagawa, S.; Noyori, R.; Takaya, H. Eur. Pat. Appl. 295,890, 1988. Chem. Abstr. 1988, 112, 138730.
13. (b) Kitamura, M.; Ohkuma, T.; Inoue, S.; Sayo, N.; Kumobayashi, H.; Akutagawa, S.; Ohta, T.; Takaya, H.; Noyori, R. J. Am. Chem. Soc. 1988, 110, 629-631.
14. 10. (a) Agbossou, F.; Carpentier, J.-F.; Hatat, C.; Kokel, N.; Mortreux, A.; Betz, P.; Goddard, R.; Krüger, C. Organometallics 1995, 14, 2480-2489.
15. (b) Roucoux, A.; Thieffry, L.; Carpentier, J.-F.; Devocelle, M.; Méliet, C.; Agbossou, F.; Mortreux, A. Organometallics 1996, 15, 2440-2449.
16. (c) Pasquier, C.; Naili, S.; Pelinski, L.; Brocard, J.; Mortreux, A.; Agbossou, F. Tetrahedron: Asymmetry 1998, 9, 193-196.
17. (d) Devocelle, M.; Agbossou, F.; Mortreux, A. Synlett 1997, 1306-1308.
18. (e) Agbossou F.; Carpentier, J.-F.; Hapiot, F.; Suisse, I.; Mortreux, A. Coord. Chem. Rev. 1998, 180, 1615-1645.
19. 11. Agbossou, F.; Devocelle, M.; Dormoy, J.-R.; Mortreux, A. PCT Int. Appl. WO 98 11,053. Chem. Abstr. 1998, 128, 243825.
20. 12. Castedo, L.; Catro, J. L.; Riguera, R. Tetrahedron Lett. 1984, 25, 1205-1208.
21. 13. Tschaen, D. M.; Abramson, L.; Cai, D.; Desmond, R.; Dolling, U.-H.; Frey, L.; Karady, S; Shi, Y.-J.; Verhoeven, R. J. Org. Chem. 1995, 60, 4324-4330.